Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia
Results
Phase 3
This trial compared blinatumomab with chemotherapy for people who have acute lymphoblastic leukaemia (ALL).
It was for people with ALL that hadn’t responded to treatment or had come back after treatment.
This trial was open for people to join between January 2014 and September 2015. These results were published in 2017 and 2018.
Recruitment start: 3 January 2014
Recruitment end: 4 September 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adele Fielding
Amgen
NIHR Clinical Research Network: Cancer
Last reviewed: 09 Jul 2019
CRUK internal database number: 12064
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
